NDC 51079-670

Methotrexate

Methotrexate

Methotrexate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Inc.. The primary component is Methotrexate Sodium.

Product ID51079-670_7cef7564-6ac1-34a6-e053-2a91aa0ac2b0
NDC51079-670
Product TypeHuman Prescription Drug
Proprietary NameMethotrexate
Generic NameMethotrexate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1995-07-13
Marketing CategoryANDA / ANDA
Application NumberANDA081235
Labeler NameMylan Institutional Inc.
Substance NameMETHOTREXATE SODIUM
Active Ingredient Strength3 mg/1
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51079-670-05

20 BLISTER PACK in 1 CARTON (51079-670-05) > 1 TABLET in 1 BLISTER PACK (51079-670-01)
Marketing Start Date1995-07-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51079-670-05 [51079067005]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081235
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1995-07-13

NDC 51079-670-01 [51079067001]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081235
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1995-07-13

Drug Details

Active Ingredients

IngredientStrength
METHOTREXATE SODIUM2.5 mg/1

OpenFDA Data

SPL SET ID:8df0780e-0fbd-4ab8-80b0-7a5eaa08ec0a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 105585
  • Pharmacological Class

    • Folate Analog Metabolic Inhibitor [EPC]
    • Folic Acid Metabolism Inhibitors [MoA]

    Medicade Reported Pricing

    51079067005 METHOTREXATE 2.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    51079067001 METHOTREXATE 2.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Methotrexate" or generic name "Methotrexate"

    NDCBrand NameGeneric Name
    0143-9367MethotrexateMethotrexate
    0143-9516MethotrexateMethotrexate
    0143-9517MethotrexateMethotrexate
    0143-9518MethotrexateMethotrexate
    0143-9519MethotrexateMethotrexate
    0143-9830MethotrexateMethotrexate
    0378-0014Methotrexatemethotrexate
    0555-0572MethotrexateMethotrexate
    0703-3671MethotrexateMethotrexate
    0703-3675MethotrexateMethotrexate
    0703-3678MethotrexateMethotrexate
    68382-775MethotrexateMethotrexate
    69238-1423MethotrexateMethotrexate
    70518-0223METHOTREXATEMETHOTREXATE
    70518-1251MethotrexateMethotrexate
    70518-1398MethotrexateMethotrexate
    70771-1058MethotrexateMethotrexate
    71335-0782MethotrexateMethotrexate
    16729-277MethotrexateMethotrexate
    21695-111MethotrexateMethotrexate
    42291-594MethotrexateMethotrexate
    42254-110METHOTREXATEMETHOTREXATE
    43063-439MethotrexateMethotrexate
    47335-235MethotrexateMethotrexate
    50090-0294METHOTREXATEMETHOTREXATE
    50090-2345MethotrexateMethotrexate
    50090-3418MethotrexateMethotrexate
    51079-670MethotrexateMethotrexate
    51407-121MethotrexateMethotrexate
    61703-350MethotrexateMethotrexate
    61703-408MethotrexateMethotrexate
    63323-122MethotrexateMethotrexate
    63323-123MethotrexateMethotrexate
    66336-338METHOTREXATEMETHOTREXATE
    67253-320METHOTREXATEMETHOTREXATE
    67457-480MethotrexateMethotrexate
    67457-466MethotrexateMethotrexate
    71335-1118MethotrexateMethotrexate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.